Benzinga

77778.000.5974%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

77778.000.5974%

MERCK KGAA by Merck KGaA Stock News

MKGAFOTCPK

Trade with Public

Trade with Public

$163.71

-4.70-2.79%

At close: Sep 2, 5:00 PM EST

OverviewNewsFinancials Sentiment Compare

Latest MERCK KGAA by Merck KGaA Stock News | OTC:MKGAF | Benzinga

Get the latest news on MERCK KGAA by Merck KGaA stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on MERCK KGAA by Merck KGaA performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, August 21, 2026

Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal
Vandana Singh

Friday, July 10, 2026

Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Vandana Singh

Thursday, June 25, 2026

Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal
Vandana Singh

Thursday, April 30, 2026

Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'
Tanya Rawat

Wednesday, April 22, 2026

Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
Vandana Singh

Thursday, February 12, 2026

Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
Vandana Singh

Thursday, December 18, 2025

White House Readies Drug Price Deals With AbbVie, Novartis, Roche
Vandana Singh

Friday, October 17, 2025

Invo Fertility Stock Is Plunging After White House Announcement
Evette Mitkov
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
Vandana Singh
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
Vandana Singh

Monday, August 11, 2025

Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
Vandana Singh

Sunday, February 16, 2025

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Lekha Gupta

Tuesday, February 11, 2025

Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Vandana Singh

Monday, January 13, 2025

GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Vandana Singh

Monday, June 24, 2024

PRO
CORRECTION: Merck KGaA Ticker Is "MKGAF"
Benzinga Newsdesk
PRO
'Merck KGaA: Phase III trials of xevinapant i...
Benzinga Newsdesk

Wednesday, December 06, 2023

Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Vandana Singh

Tuesday, December 05, 2023

PRO
Germany's Merck KGaA Says Results From EVOLUT...
Benzinga Newsdesk

Tuesday, September 26, 2023

Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Vandana Singh

Thursday, August 03, 2023

Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Vandana Singh

Wednesday, July 26, 2023

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Vandana Singh

Friday, June 30, 2023

Watching Abcam; Co Seeing Takeover Interest From Danaher, Agilent Technologies, Germany's Merck KGaA
Happy Mohamed

Tuesday, June 20, 2023

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Vandana Singh

Wednesday, May 17, 2023

Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Vandana Singh

Tuesday, April 18, 2023

Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Vandana Singh

Wednesday, April 12, 2023

FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Vandana Singh

Monday, March 27, 2023

Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Vandana Singh

Thursday, March 23, 2023

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Vandana Singh

Tuesday, January 03, 2023

PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Vandana Singh

Friday, December 23, 2022

Mersana Inks Cancer Therapy Development Deal With Merck Germany
Vandana Singh

Thursday, September 30, 2021

GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Vandana Singh

Tuesday, September 21, 2021

Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Vandana Singh

Tuesday, August 24, 2021

Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Vandana Singh

Tuesday, June 01, 2021

Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
Vandana Singh
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors
Vandana Singh
Immutep Announced New Collaboration with Merck KGaA, Darmstadt, Germany for LAG-3 Therapy, Efti
Charles Gross

Friday, May 14, 2021

Gene Therapy Player Vera Therapeutics Prices IPO Well Below Range At $11/Share
Vandana Singh

Monday, May 10, 2021

UK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer
Vandana Singh

Tuesday, April 20, 2021

Palantir Deepens Relationship With Ringier To Help It Transform Into A Digital-First, Global Media Company
Shanthi Rexaline

Wednesday, April 07, 2021

Novartis Taps Artios In Discovery Pact To Enhance Radioligand Portfolio
Vandana Singh

Thursday, March 18, 2021

Exelixis' XL092 To Be Tested In Combination With Bavencio In Urothelial Carcinoma
Vandana Singh

Wednesday, March 17, 2021

Germany's Merck Invests In French Facility For Single Use Products
Vandana Singh

Monday, January 25, 2021

Pfizer Announced EC Approved BAVENCIO for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Charles Gross

Thursday, January 14, 2021

Philips, Merck KGaA Partner to Develop Personalized Fertility Treatment Solutions
Charles Gross

Tuesday, November 24, 2020

The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
Shanthi Rexaline

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights

Friday, January 10, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Thursday, January 09, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Monday, June 15, 2015

EU Approves Merck Acquisition of Sigma-Aldrich Subject to Conditions
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved